Exciting new evidence is emerging from the discovery that ARID1A-mutant cancer cells are highly vulnerable to loss of ARID1B expression [9], and similarly for BRG1/SMARCA4-mutated cancers to the loss of BRM/SMARCA2 [10]. This evidence concerns the gene SMARCA4 and cancer.